QSI

+ Watchlist + Portfolio

Quantum-Si Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.77
52-Week Range: $0.69 – $3.10
Market Cap: $170.73M
P/E (TTM): —
EPS (TTM): -0.46
Dividend Yield: —

Advanced Metrics

Price/Book: 0.95
PEG Ratio: —
Return on Equity: -49.11%
Return on Assets: -26.47%
Gross Margin: 35.02%
Operating Margin: -7450.29%
Profit Margin: 0.00%
Current Ratio: 9.97
Debt/Equity: 0.02
Total Debt: $3.25M
Free Cash Flow: $-52.17M
Revenue Growth: -41.80%
Earnings Growth: —
Enterprise Value: $62.24M

QSI Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0.00	$1.08M	$3.06M	$2.44M
Cost of Revenue	$0.00	$594.00K	$1.46M	$1.28M
Gross Profit	$0.00	$488.00K	$1.60M	$1.15M
Research & Development	$72.06M	$67.03M	$59.64M	$53.76M
Selling, General & Admin	$42.30M	$44.63M	$50.53M	$44.75M
Operating Expenses	$114.36M	$111.66M	$110.18M	$98.51M
Operating Income	-$114.36M	-$111.17M	-$108.58M	-$97.36M
EBITDA	-$111.77M	-$107.02M	-$103.98M	-$92.91M
Pretax Income	-$132.44M	-$95.96M	-$100.95M	-$101.28M
Income Tax	$0.00	$0.00	$56.00K	$58.00K
Net Income	-$132.44M	-$95.96M	-$101.01M	-$101.34M
Diluted EPS	-0.95	-0.68	-0.71	-0.51
Diluted Shares	139.26M	139.25M	143.20M	197.76M

QSI Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$84.32M	$133.86M	$49.24M	$21.64M
Receivables	$0.00	$368.00K	$1.33M	$5.20M
Inventory	$0.00	$3.94M	$4.07M	$3.20M
Current Assets	$358.18M	$266.31M	$218.01M	$175.86M
Total Assets	$391.49M	$298.25M	$247.87M	$245.61M
Current Liabilities	$15.71M	$11.61M	$18.19M	$23.02M
Total Debt	$17.45M	$15.30M	$12.95M	$4.17M
Total Liabilities	$32.78M	$26.63M	$32.45M	$25.38M
Retained Earnings	-$399.67M	-$495.63M	-$596.64M	-$697.98M
Shareholders' Equity	$358.71M	$271.62M	$215.42M	$220.23M
Working Capital	$342.48M	$254.70M	$199.82M	$152.84M

QSI Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$90.56M	-$94.04M	-$87.80M	-$94.72M
Capital Expenditure	-$10.74M	-$5.27M	-$4.64M	-$2.52M
Free Cash Flow	-$101.30M	-$99.31M	-$92.44M	-$97.23M
Depreciation & Amortisation	$2.58M	$4.16M	$4.60M	$4.45M
Stock-Based Compensation	$11.21M	$8.52M	$8.89M	$10.77M
Investing Cash Flow	$137.19M	$143.43M	-$32.67M	-$28.32M
Financing Cash Flow	$1.91M	$149.00K	$35.88M	$95.42M
Net Change in Cash	$48.53M	$49.54M	-$84.59M	-$27.61M

QSI Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$842.00K	$591.00K	$552.00K	$451.00K	$258.00K
Cost of Revenue	$356.00K	$240.00K	$358.00K	$329.00K	$184.00K
Gross Profit	$486.00K	$351.00K	$194.00K	$122.00K	$74.00K
Research & Development	$13.72M	$15.21M	$13.88M	$10.95M	$14.49M
Selling, General & Admin	$11.88M	$11.90M	$10.71M	$10.27M	$9.64M
Operating Expenses	$25.60M	$27.11M	$24.59M	$21.22M	$24.13M
Operating Income	-$25.11M	-$26.76M	-$24.40M	-$21.09M	-$24.05M
EBITDA	-$24.20M	-$25.57M	-$23.22M	-$19.92M	-$22.83M
Pretax Income	-$19.18M	-$28.82M	-$35.68M	-$17.60M	-$21.79M
Income Tax	$11.00K	$20.00K	$19.00K	$8.00K	-$122.00K
Net Income	-$19.19M	-$28.84M	-$35.70M	-$17.61M	-$21.67M
Diluted EPS	-0.11	-0.16	-0.17	-0.08	-0.10
Diluted Shares	182.30M	183.63M	209.04M	209.19M	216.47M

QSI Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$37.29M	$22.19M	$30.91M	$21.64M	$36.20M
Receivables	$1.03M	$5.55M	$5.39M	$5.20M	$203.00K
Inventory	$4.42M	$3.90M	$3.51M	$3.20M	$2.19M
Current Assets	$241.81M	$226.47M	$237.99M	$175.86M	$134.96M
Total Assets	$271.22M	$254.41M	$260.13M	$245.61M	$213.35M
Current Liabilities	$12.57M	$24.02M	$22.15M	$23.02M	$10.71M
Total Debt	$12.05M	$11.14M	$4.61M	$4.17M	$3.71M
Total Liabilities	$24.30M	$33.42M	$24.97M	$25.38M	$12.60M
Retained Earnings	-$615.83M	-$644.67M	-$680.37M	-$697.98M	-$719.65M
Shareholders' Equity	$246.92M	$220.98M	$235.16M	$220.23M	$200.74M
Working Capital	$229.24M	$202.46M	$215.84M	$152.84M	$124.25M

QSI Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$26.15M	-$20.20M	-$32.02M	-$16.35M	-$25.64M
Capital Expenditure	-$1.31M	-$327.00K	-$900.00K	—	-$279.00K
Free Cash Flow	-$27.46M	-$20.52M	-$32.92M	-$16.33M	-$25.92M
Depreciation & Amortisation	$917.00K	$1.19M	$1.17M	$1.17M	$1.23M
Stock-Based Compensation	$2.36M	$2.90M	$2.83M	$2.69M	$2.56M
Investing Cash Flow	-$34.17M	$5.04M	-$6.21M	$7.02M	$40.27M
Financing Cash Flow	$48.37M	$41.00K	$46.95M	$54.00K	$0.00
Net Change in Cash	-$11.95M	-$15.12M	$8.73M	-$9.27M	$14.63M

Market Snapshot

About

Quantum-Si is pioneering next-generation protein sequencing technology using semiconductor chips. The company has developed a benchtop platform that enables massively parallel, single-molecule protein analysis, aiming to do for proteomics what next-gen sequencing did for genomics. Quantum-Si targets applications in drug discovery, diagnostics, and life sciences research.